Three private companies are merging to create a new entity in the psychedelics space.
Three private companies are merging to create a new entity in the psychedelics space.
Novamind Ventures Inc. is preparing to go public via amalgamation with unlisted public company, Hinterland Metals Inc.
The Psychedelics Revolution. One part changing social attitudes. One part medical necessity. One part hard economics.
Red Light Holland makes move into medicinal psychedelic applications.
Entheon Biomedical announces a three-cornered amalgamation with MPV Exploration along with concurrent financing.
Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.
Field Trip announces a new therapeutic program as the company prepares for its coming RTO.
Psychedelic drugs are a potential huge step forward in the treatment of an affliction that currently offers very poor treatment options.
Champignon Brands closes on a $15 million financing to expand its clinical psychedelics research programs.
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now